MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Legmain/Asparaginyl endopeptidase-resistant tau fibril fold produces corticobasal degeneration-specific C-terminal tau fragment

    D. Taniguchi, T. Hatano, Y. Imai, N. Hattori (Tokyo, Japan)

    Objective: This study monitored the formation of CBD (corticobasal degeneration)-type fibrils that exhibit astrocytic plaques, a characteristic CBD pathology, using Legumain-cleavage site-specific antibodies and CBD-specific…
  • 2024 International Congress

    Combined application of alpha-synuclein and 4-repeat tau seed amplification assays for the differential diagnosis of parkinsonian disorders

    E. Jabbari, E. Artikis, C. Orru`, D. Vaughan, N. Vijiaratnam, R. Fumi, M. Theilmann Jensen, M. Hodgson, T. Georgiades, L. Wu, D. Lux, R. Obrocki, B. Groveman, A. Hughson, O. Ansorge, K. Allinson, T. Warner, Z. Jaunmuktane, A. Misbahuddin, N. Leigh, B. Ghosh, K. Bhatia, A. Church, C. Kobylecki, M. Hu, J. Rowe, C. Blauwendraat, T. Foltynie, H. Morris, B. Caughey (London, United Kingdom)

    Objective: To assess alpha-synuclein (a-syn) and 4-repeat tau (4RT) seed amplification assay (SAA) positivity rates in biosamples from people with Parkinson’s disease (PD) and Progressive…
  • 2024 International Congress

    Hydrocephalic Progressive Supranuclear Palsy: An Underrecognized Entity

    A. Premkumar, D. Lim, SK. Seetharaman, LF. Tan (Singapore, Singapore)

    Objective: We describe a case of NPH-like presentation of PSP, review literature surrounding this entity, and discuss key diagnostic considerations and implications. Background: Despite advances…
  • 2024 International Congress

    Path To Prevention (P2P) Therapeutics Platform Trial in Stage 2B Neuronal Alpha-Synuclein Disease: Study Update

    T. Simuni, C. Coffey, A. Siderowf, C. Tanner, S. Chowdhury, T. Sherer, C. Kopil, K. Kieburtz, B. Saville, C. Allen-Savietta, B. Wendelberger, A. Crawford, K. Fabrizio, K. Marek (Chicago, USA)

    Objective: To describe the study design and timeline of the first interventional study in  Neuronal α-Synuclein Disease (NSD). Background: P2P is a platform, Phase 2…
  • 2024 International Congress

    New α-Synuclein Strain Biomarker in Parkinson’s Disease and Related Dementia

    K. Gadhave, R. Chen, V. Dawson, T. Dawson, L. Rosenthal, X. Mao ()

    Objective: Biomarker development for Parkinson’s disease and related dementia. Background: α-Synuclein (α-syn) strains can serve as discriminators of Parkinson's disease (PD) from other α-synucleinopathies. However,…
  • 2024 International Congress

    Association of β-Amyloid Load on PET with Cognitive Profiles Across the Lewy Body Diseases Continuum

    KA. Woo, EJ. Yoon, SY. Kim, HJ. Kim, BR. Jin, SM. Lee, HW. Nam, HW. Park, YK. Kim, JY. Lee (Seoul, Republic of Korea)

    Objective: To investigate the association between Aβ accumulation and clinical characteristics across the Lewy body disease (LBD) spectrum, with a specific focus on global and…
  • 2024 International Congress

    Trihexyphenidyl Use in a Parkinsonian Phenotype of Gerstman-Sträussler-Scheinker Syndrome

    P. Atit, S. Aradi (Tampa, USA)

    Objective: To highlight clinical improvement in a patient with a parkinsonian presentation of Gerstmann-Sträussler-Scheinker (GSS) syndrome who was treated with trihexyphenidyl. Background: GSS is a…
  • 2024 International Congress

    Behind the wheel with Parkinson’s-Older patients’ review

    M. Khwaja, G. Pun, T. Nanayakkara, R. Miah, A. Chatterjee, N. Butt, T. Zubair (Reading, United Kingdom)

    Objective: To review characteristics of older Parkinson’s patients undergoing driving assessments presenting to Movements disorder’s clinic at Royal Berkshire Hospital, Reading,UK. Background: Parkinson’s leads to…
  • 2024 International Congress

    Body Mass Index as a Possible Poor Prognostic Factor in Motor and Postural Condition Through the Evaluation of MDS-UPDRS 3.3 – 3.18 in Patients with Parkinson’s.

    C. álvarez-Hernández, R. Baños-Betancourt, K. Velazquez-Roman, G. Rivera-Monroy, A. Guerra-Anzaldo, W. Moguel-Cardín, A. Domínguez-García, D. Romero-Terán, A. Regalado-Mustafá, J. Delgado-Uriarte, N. Moreno-Aldama, A. Uribe Leon, M. Unda-Mcfarlane, A. Cervantes-Arriaga, M. Rodriguez-Violante, D. Luna-Escamilla, K. Gonzalez-Rosas, U. Ugalde-Miranda, F. Moralez-Gonzalez, M. Cabrera-Jimenez (Mexico City, Mexico)

    Objective: To determine the degree of motor and postural impairment of patients with Parkinson's Disease at the time of their first consultation according to the…
  • 2024 International Congress

    Disease-related comprehensive motor pattern derived from 2D single RGB video as a biomarker for early and prodromal Parkinson disease

    JH. Shin, SM. Lee, CH. Jeong, R. Yu, SH. Ha, S. Kim, B. Jin, KA. Woo, KY. Jung, JY. Lee, HJ. Kim, B. Jeon (Seoul, Republic of Korea)

    Objective: This study aims to develop a disease-related motor pattern from a single 2D RGB video as a biomarker for early diagnosis and monitoring of…
  • « Previous Page
  • 1
  • …
  • 148
  • 149
  • 150
  • 151
  • 152
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley